India Orphan Drugs Market Import Shipment Trend (2020-2024)
The India orphan drugs market import shipment demonstrated robust growth with a notable CAGR from 2020-2024. However, there was a slight decline in growth momentum between 2023 and 2024. Overall, the market expansion trend remained strong despite the temporary slowdown in the final year.
India Orphan Drugs Market Synopsis
India is one of the most populated countries in the world with a large number of orphan diseases, especially among its rural population. As per estimates, more than 1.2 million people suffer from rare and neglected diseases in India. The lack of awareness about these diseases often results in delayed diagnosis and treatment for such patients, adversely affecting their health outcomes and prognosis. Moreover, limited access to life-saving drugs further adds to their suffering as very few companies are involved in the development of drugs for orphan indications due to low potential returns on investment (ROI). To bridge this gap between demand and supply of medicines for rare disorders, several initiatives have been taken by both government and non-government organizations which has resulted in increased distribution channels across the country resulting in higher adoption rate of orphan drugs.
Drivers of the Market:
The key drivers driving growth of India Orphan Drugs Market include recent developments & approvals related to drug manufacturing facilities; rising prevalence/ incidence rates; increasing awareness regarding availability & benefits associated with usage of these medications; favorable regulations by national regulatory bodies; support from government programs like Jan Aushadhi Scheme etc. Furthermore, expansion activities undertaken by prominent pharmaceutical companies coupled with implementation strategies adopted by respective governments will further fuel market growth during 2025 ? 2025 time period.
Challenges of the Market:
Despite various positive developments taking place within Indian healthcare sector related to availability & affordability issues concerning availability & usage patterns pertaining to therapeutic products used for treating rare illnesses, there still exists certain challenges that need immediate attention including lack skilled personnel at diagnostic centers/hospitals who can accurately diagnose conditions related with rare disorders along with general unawareness levels amongst common public across different parts rural areas where majority cases are reported every year.. In addition poor infrastructure facilities available at most healthcare setups also complicate matters thereby limiting treatment options available at disposal medical professionals leading overall increase mortality rates particularly children below age 5 years old.
Trends of the Market:
A major trend being observed currently within India?s Orphan Drugs Market is rise collaborative partnerships between local players existing global pharma giants aiming intensifying efforts towards research development new innovative therapies specifically designed treat those ailments falling under umbrella term ?orphan disease? . Another noteworthy trend includes shift focus short lifespan treatments long duration ones provide better quality life individuals so diagnosed while simultaneously reducing cost incurred over entire course medication period . Last but not least growing inclination alternative forms therapy such homeopathy ayurveda gaining popularity many circles making it.
Key Highlights of the Report:
- India Orphan Drugs Market Outlook
- Market Size of India Orphan Drugs Market, 2024
- Forecast of India Orphan Drugs Market, 2031
- Historical Data and Forecast of India Orphan Drugs Revenues & Volume for the Period 2021-2031
- India Orphan Drugs Market Trend Evolution
- India Orphan Drugs Market Drivers and Challenges
- India Orphan Drugs Price Trends
- India Orphan Drugs Porter's Five Forces
- India Orphan Drugs Industry Life Cycle
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Drugs for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Revlimid for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Rituxan for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Opdivo for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Keytruda for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Imbruvica for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Soliris for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Other Orphan Drugs for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Drug Type for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Biologics for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Non-Biologics for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Therapy Class for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Oncology for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Blood for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Endocrine for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Central Nervous Systems for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Cardiovascular for the Period 2021-2031
- Historical Data and Forecast of India Orphan Drugs Market Revenues & Volume By Respiratory for the Period 2021-2031
- India Orphan Drugs Import Export Trade Statistics
- Market Opportunity Assessment By Drugs
- Market Opportunity Assessment By Drug Type
- Market Opportunity Assessment By Therapy Class
- India Orphan Drugs Top Companies Market Share
- India Orphan Drugs Competitive Benchmarking By Technical and Operational Parameters
- India Orphan Drugs Company Profiles
- India Orphan Drugs Key Strategic Recommendations
